Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 5.96169249 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.96169249 |
3 | L-phenylalanine metabolic process (GO:0006558) | 5.82806256 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.82806256 |
5 | alpha-linolenic acid metabolic process (GO:0036109) | 5.48470667 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.45647073 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 5.36368161 |
8 | cysteine metabolic process (GO:0006534) | 4.89769141 |
9 | glyoxylate metabolic process (GO:0046487) | 4.89394166 |
10 | complement activation, alternative pathway (GO:0006957) | 4.87509389 |
11 | kynurenine metabolic process (GO:0070189) | 4.85703447 |
12 | indolalkylamine catabolic process (GO:0046218) | 4.82160694 |
13 | tryptophan catabolic process (GO:0006569) | 4.82160694 |
14 | indole-containing compound catabolic process (GO:0042436) | 4.82160694 |
15 | sulfur amino acid catabolic process (GO:0000098) | 4.79825577 |
16 | bile acid biosynthetic process (GO:0006699) | 4.77241158 |
17 | urea cycle (GO:0000050) | 4.76363313 |
18 | urea metabolic process (GO:0019627) | 4.76363313 |
19 | regulation of triglyceride catabolic process (GO:0010896) | 4.72803824 |
20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.71312374 |
21 | valine metabolic process (GO:0006573) | 4.69587977 |
22 | lysine catabolic process (GO:0006554) | 4.65501612 |
23 | lysine metabolic process (GO:0006553) | 4.65501612 |
24 | tryptophan metabolic process (GO:0006568) | 4.62307597 |
25 | protein carboxylation (GO:0018214) | 4.59655410 |
26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.59655410 |
27 | regulation of protein activation cascade (GO:2000257) | 4.54583065 |
28 | homocysteine metabolic process (GO:0050667) | 4.46960778 |
29 | amino-acid betaine metabolic process (GO:0006577) | 4.35294970 |
30 | nitrogen cycle metabolic process (GO:0071941) | 4.33849177 |
31 | regulation of complement activation (GO:0030449) | 4.31859102 |
32 | high-density lipoprotein particle remodeling (GO:0034375) | 4.31815713 |
33 | proteasome assembly (GO:0043248) | 4.29816236 |
34 | CENP-A containing nucleosome assembly (GO:0034080) | 4.29454869 |
35 | serine family amino acid catabolic process (GO:0009071) | 4.27547928 |
36 | ribosome assembly (GO:0042255) | 4.27378959 |
37 | negative regulation of fibrinolysis (GO:0051918) | 4.24049531 |
38 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.22488076 |
39 | chromatin remodeling at centromere (GO:0031055) | 4.16470019 |
40 | bile acid metabolic process (GO:0008206) | 4.15703584 |
41 | acylglycerol homeostasis (GO:0055090) | 4.08994406 |
42 | triglyceride homeostasis (GO:0070328) | 4.08994406 |
43 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.04308238 |
44 | regulation of fibrinolysis (GO:0051917) | 4.02254375 |
45 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.01917017 |
46 | plasma lipoprotein particle clearance (GO:0034381) | 3.98831218 |
47 | ethanol oxidation (GO:0006069) | 3.96316913 |
48 | fatty acid beta-oxidation (GO:0006635) | 3.93141196 |
49 | glycine metabolic process (GO:0006544) | 3.91703283 |
50 | tyrosine metabolic process (GO:0006570) | 3.88475782 |
51 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.88265122 |
52 | establishment of integrated proviral latency (GO:0075713) | 3.87665976 |
53 | aromatic amino acid family metabolic process (GO:0009072) | 3.87170577 |
54 | DNA strand elongation (GO:0022616) | 3.86786840 |
55 | positive regulation of lipid catabolic process (GO:0050996) | 3.85867439 |
56 | reverse cholesterol transport (GO:0043691) | 3.85691147 |
57 | 2-oxoglutarate metabolic process (GO:0006103) | 3.85204841 |
58 | protein-lipid complex remodeling (GO:0034368) | 3.85119753 |
59 | macromolecular complex remodeling (GO:0034367) | 3.85119753 |
60 | plasma lipoprotein particle remodeling (GO:0034369) | 3.85119753 |
61 | phospholipid efflux (GO:0033700) | 3.84251922 |
62 | alpha-amino acid catabolic process (GO:1901606) | 3.82337953 |
63 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.80551217 |
64 | fatty acid oxidation (GO:0019395) | 3.79114254 |
65 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.75631238 |
66 | bile acid and bile salt transport (GO:0015721) | 3.74380297 |
67 | tricarboxylic acid cycle (GO:0006099) | 3.73845144 |
68 | cellular ketone body metabolic process (GO:0046950) | 3.72752732 |
69 | negative regulation of cholesterol transport (GO:0032375) | 3.70990900 |
70 | negative regulation of sterol transport (GO:0032372) | 3.70990900 |
71 | lipid oxidation (GO:0034440) | 3.70116324 |
72 | negative regulation of ligase activity (GO:0051352) | 3.65141530 |
73 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.65141530 |
74 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.65036583 |
75 | purine nucleobase biosynthetic process (GO:0009113) | 3.63380261 |
76 | fatty acid catabolic process (GO:0009062) | 3.62632310 |
77 | serine family amino acid metabolic process (GO:0009069) | 3.58459516 |
78 | regulation of cholesterol esterification (GO:0010872) | 3.58170193 |
79 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.58154200 |
80 | cellular amino acid catabolic process (GO:0009063) | 3.57827642 |
81 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.55745497 |
82 | carnitine metabolic process (GO:0009437) | 3.55554741 |
83 | short-chain fatty acid metabolic process (GO:0046459) | 3.54024233 |
84 | positive regulation of fatty acid oxidation (GO:0046321) | 3.51907447 |
85 | monocarboxylic acid catabolic process (GO:0072329) | 3.51217501 |
86 | DNA replication checkpoint (GO:0000076) | 3.50785427 |
87 | triglyceride catabolic process (GO:0019433) | 3.49577988 |
88 | acetyl-CoA metabolic process (GO:0006084) | 3.49317589 |
89 | cellular modified amino acid catabolic process (GO:0042219) | 3.45577059 |
90 | phospholipid homeostasis (GO:0055091) | 3.43512825 |
91 | imidazole-containing compound metabolic process (GO:0052803) | 3.42777947 |
92 | DNA ligation (GO:0006266) | 3.42542841 |
93 | indolalkylamine metabolic process (GO:0006586) | 3.41969920 |
94 | cellular glucuronidation (GO:0052695) | 3.41301711 |
95 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.40736273 |
96 | histone exchange (GO:0043486) | 3.40168629 |
97 | acylglycerol catabolic process (GO:0046464) | 3.39745877 |
98 | neutral lipid catabolic process (GO:0046461) | 3.39745877 |
99 | tricarboxylic acid metabolic process (GO:0072350) | 3.39492744 |
100 | cullin deneddylation (GO:0010388) | 3.39105386 |
101 | benzene-containing compound metabolic process (GO:0042537) | 3.37765846 |
102 | plasma lipoprotein particle assembly (GO:0034377) | 3.36945720 |
103 | organic acid catabolic process (GO:0016054) | 3.36649747 |
104 | carboxylic acid catabolic process (GO:0046395) | 3.36649747 |
105 | oxaloacetate metabolic process (GO:0006107) | 3.35277638 |
106 | low-density lipoprotein particle clearance (GO:0034383) | 3.34908072 |
107 | branched-chain amino acid metabolic process (GO:0009081) | 3.30367437 |
108 | fatty acid transmembrane transport (GO:1902001) | 3.28685896 |
109 | serine family amino acid biosynthetic process (GO:0009070) | 3.27343782 |
110 | negative regulation of lipase activity (GO:0060192) | 3.27112951 |
111 | regulation of cholesterol homeostasis (GO:2000188) | 3.26748028 |
112 | IMP biosynthetic process (GO:0006188) | 3.26456333 |
113 | coenzyme catabolic process (GO:0009109) | 3.26040462 |
114 | lipoprotein metabolic process (GO:0042157) | 3.25986190 |
115 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.25064245 |
116 | protein deneddylation (GO:0000338) | 3.22685377 |
117 | cholesterol homeostasis (GO:0042632) | 3.22523255 |
118 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.22256218 |
119 | regulation of sequestering of triglyceride (GO:0010889) | 3.22029674 |
120 | cholesterol efflux (GO:0033344) | 3.21984358 |
121 | glutamate metabolic process (GO:0006536) | 3.21805308 |
122 | DNA replication-independent nucleosome organization (GO:0034724) | 3.20940114 |
123 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.20940114 |
124 | nucleobase biosynthetic process (GO:0046112) | 3.20892071 |
125 | biotin metabolic process (GO:0006768) | 3.19825585 |
126 | sterol homeostasis (GO:0055092) | 3.19404549 |
127 | branched-chain amino acid catabolic process (GO:0009083) | 3.18514855 |
128 | regulation of mitochondrial translation (GO:0070129) | 3.17393334 |
129 | complement activation (GO:0006956) | 3.16819955 |
130 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.16801450 |
131 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.15074254 |
132 | oxidative phosphorylation (GO:0006119) | 3.13863676 |
133 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.13268494 |
134 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.13268494 |
135 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.13268494 |
136 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.12623413 |
137 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.12623413 |
138 | NADH metabolic process (GO:0006734) | 3.12320397 |
139 | positive regulation of ligase activity (GO:0051351) | 3.11738960 |
140 | telomere maintenance via recombination (GO:0000722) | 3.07353969 |
141 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.06756514 |
142 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.06756514 |
143 | L-methionine salvage (GO:0071267) | 3.05576885 |
144 | L-methionine biosynthetic process (GO:0071265) | 3.05576885 |
145 | amino acid salvage (GO:0043102) | 3.05576885 |
146 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.04395638 |
147 | rRNA modification (GO:0000154) | 3.02654872 |
148 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.01350087 |
149 | L-serine metabolic process (GO:0006563) | 3.01046783 |
150 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.99568324 |
151 | tetrahydrofolate metabolic process (GO:0046653) | 2.97118458 |
152 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.96787562 |
153 | DNA double-strand break processing (GO:0000729) | 2.93074683 |
154 | mitotic metaphase plate congression (GO:0007080) | 2.92600333 |
155 | mitotic recombination (GO:0006312) | 2.92311014 |
156 | regulation of ligase activity (GO:0051340) | 2.91125506 |
157 | pseudouridine synthesis (GO:0001522) | 2.91086500 |
158 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.88938634 |
159 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.88938634 |
160 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.84121817 |
161 | establishment of viral latency (GO:0019043) | 2.82821718 |
162 | regulation of cellular amine metabolic process (GO:0033238) | 2.81870293 |
163 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.81631797 |
164 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.81485460 |
165 | cell cycle G1/S phase transition (GO:0044843) | 2.81485460 |
166 | IMP metabolic process (GO:0046040) | 2.80474001 |
167 | regulation of centriole replication (GO:0046599) | 2.79382521 |
168 | mitotic sister chromatid segregation (GO:0000070) | 2.77864293 |
169 | protein localization to kinetochore (GO:0034501) | 2.77342190 |
170 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.75968703 |
171 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.75962320 |
172 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.75962320 |
173 | formation of translation preinitiation complex (GO:0001731) | 2.75873873 |
174 | histone mRNA metabolic process (GO:0008334) | 2.75180696 |
175 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.73379197 |
176 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.73379197 |
177 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.73179813 |
178 | viral mRNA export from host cell nucleus (GO:0046784) | 2.72261318 |
179 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.71617175 |
180 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.71261587 |
181 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.71261587 |
182 | isotype switching (GO:0045190) | 2.71261587 |
183 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.68291435 |
184 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.66668042 |
185 | non-recombinational repair (GO:0000726) | 2.66668042 |
186 | DNA unwinding involved in DNA replication (GO:0006268) | 2.65775852 |
187 | protein targeting to mitochondrion (GO:0006626) | 2.65497927 |
188 | DNA damage response, detection of DNA damage (GO:0042769) | 2.65367580 |
189 | spliceosomal snRNP assembly (GO:0000387) | 2.64465585 |
190 | telomere maintenance via telomere lengthening (GO:0010833) | 2.62996422 |
191 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.62264413 |
192 | DNA replication initiation (GO:0006270) | 2.59929279 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.35810839 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.62216971 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.55328343 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.82492525 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.05663538 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.04131241 |
7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.01573219 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.12455957 |
9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.60968739 |
10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.58496276 |
11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.41457080 |
12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.39993084 |
13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.22161162 |
14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.16465709 |
15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.10601513 |
16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.09726211 |
17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.08509481 |
18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.08443603 |
19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.94912448 |
20 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.93925510 |
21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.84362987 |
22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.71405077 |
23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.68163390 |
24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.64890180 |
25 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.63407502 |
26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.62423618 |
27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.59856450 |
28 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.57360635 |
29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.53015489 |
30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.46530257 |
31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.41522492 |
32 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.35391451 |
33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.34586397 |
34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.31801002 |
35 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.21578584 |
36 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.19219738 |
37 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.16743520 |
38 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.13988814 |
39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.12716024 |
40 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.12437121 |
41 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.09750082 |
42 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.04199476 |
43 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.98248186 |
44 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.97785739 |
45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.97592977 |
46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.96887479 |
47 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.93644075 |
48 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.87997933 |
49 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80731840 |
50 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.80685561 |
51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.74844390 |
52 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.74797412 |
53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.74158123 |
54 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.73503755 |
55 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.71587304 |
56 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.69800789 |
57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69255929 |
58 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.68053558 |
59 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.61919198 |
60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.59084174 |
61 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.57485098 |
62 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.47714157 |
63 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40851445 |
64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.36897840 |
65 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.36080439 |
66 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.35620191 |
67 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.32664329 |
68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.31134463 |
69 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.30911159 |
70 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.22249679 |
71 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.21688334 |
72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20064745 |
73 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18738085 |
74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.17190457 |
75 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16062651 |
76 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15099301 |
77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14794628 |
78 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.14498770 |
79 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12293233 |
80 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11639237 |
81 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.11105158 |
82 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09954019 |
83 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.07148295 |
84 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07035464 |
85 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06575426 |
86 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.06347529 |
87 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.05992438 |
88 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05759984 |
89 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.04871788 |
90 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02661108 |
91 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.01957885 |
92 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01876581 |
93 | MYC_22102868_ChIP-Seq_BL_Human | 1.00811975 |
94 | VDR_22108803_ChIP-Seq_LS180_Human | 1.00364429 |
95 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99749750 |
96 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99021778 |
97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98342054 |
98 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97754577 |
99 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96579890 |
100 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94790194 |
101 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93139650 |
102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92647819 |
103 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.91559081 |
104 | EWS_26573619_Chip-Seq_HEK293_Human | 0.91520724 |
105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91134324 |
106 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.90512790 |
107 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.88772517 |
108 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88256948 |
109 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.87469847 |
110 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.87232545 |
111 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.83823920 |
112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83629150 |
113 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.82907595 |
114 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.80620006 |
115 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.78517765 |
116 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.76503544 |
117 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.76435426 |
118 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.75686449 |
119 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.75670717 |
120 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.75299440 |
121 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75129305 |
122 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.75103081 |
123 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.74170085 |
124 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74146314 |
125 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.73828202 |
126 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.73815243 |
127 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.73667212 |
128 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.73262284 |
129 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.72529096 |
130 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.72520292 |
131 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.72207928 |
132 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72152184 |
133 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71930901 |
134 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.71543971 |
135 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.71167083 |
136 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70430386 |
137 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.70011818 |
138 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69809577 |
139 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.69631290 |
140 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.69005615 |
141 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.68905048 |
142 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.68699531 |
143 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.68409967 |
144 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.68041040 |
145 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.67747501 |
146 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67544085 |
147 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.67357464 |
148 | ATF3_27146783_Chip-Seq_COLON_Human | 0.66907178 |
149 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.66644223 |
150 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.65999425 |
151 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65940888 |
152 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65825999 |
153 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.64528450 |
154 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.64326274 |
155 | GATA1_19941826_ChIP-Seq_K562_Human | 0.63979449 |
156 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.63730150 |
157 | MAF_26560356_Chip-Seq_TH1_Human | 0.63245850 |
158 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.63005230 |
159 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.62545808 |
160 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.59276918 |
161 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58686263 |
162 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.57904443 |
163 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.57726454 |
164 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.57493886 |
165 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.57385285 |
166 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.56885546 |
167 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.56646913 |
168 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.56478365 |
169 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.56452111 |
170 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.55453461 |
171 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54422472 |
172 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.54232295 |
173 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.54081815 |
174 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.54072554 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.79085088 |
2 | MP0005360_urolithiasis | 6.10659777 |
3 | MP0005365_abnormal_bile_salt | 5.06740716 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.05120146 |
5 | MP0010094_abnormal_chromosome_stability | 3.97540312 |
6 | MP0003693_abnormal_embryo_hatching | 3.79871150 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.68023890 |
8 | MP0004957_abnormal_blastocyst_morpholog | 3.63009005 |
9 | MP0010329_abnormal_lipoprotein_level | 3.28022271 |
10 | MP0003252_abnormal_bile_duct | 3.27806678 |
11 | MP0008058_abnormal_DNA_repair | 3.20526095 |
12 | MP0003806_abnormal_nucleotide_metabolis | 3.20101314 |
13 | MP0003111_abnormal_nucleus_morphology | 3.12571583 |
14 | MP0003077_abnormal_cell_cycle | 2.76268220 |
15 | MP0008057_abnormal_DNA_replication | 2.64384619 |
16 | MP0008932_abnormal_embryonic_tissue | 2.54539580 |
17 | MP0001666_abnormal_nutrient_absorption | 2.48442770 |
18 | MP0003941_abnormal_skin_development | 2.47983123 |
19 | MP0009840_abnormal_foam_cell | 2.46657172 |
20 | MP0005083_abnormal_biliary_tract | 2.37379452 |
21 | MP0003191_abnormal_cellular_cholesterol | 2.30992293 |
22 | MP0008007_abnormal_cellular_replicative | 2.23055138 |
23 | MP0003718_maternal_effect | 2.16862728 |
24 | MP0005332_abnormal_amino_acid | 2.10444707 |
25 | MP0000609_abnormal_liver_physiology | 2.10436158 |
26 | MP0005670_abnormal_white_adipose | 2.09571580 |
27 | MP0003195_calcinosis | 2.05082433 |
28 | MP0003705_abnormal_hypodermis_morpholog | 2.05032707 |
29 | MP0003786_premature_aging | 2.04689402 |
30 | MP0004215_abnormal_myocardial_fiber | 1.93522847 |
31 | MP0002118_abnormal_lipid_homeostasis | 1.90876815 |
32 | MP0006035_abnormal_mitochondrial_morpho | 1.81303708 |
33 | MP0001727_abnormal_embryo_implantation | 1.80815382 |
34 | MP0001730_embryonic_growth_arrest | 1.76024641 |
35 | MP0005319_abnormal_enzyme/_coenzyme | 1.68783273 |
36 | MP0004019_abnormal_vitamin_homeostasis | 1.67762854 |
37 | MP0004130_abnormal_muscle_cell | 1.65650540 |
38 | MP0002138_abnormal_hepatobiliary_system | 1.60855042 |
39 | MP0003868_abnormal_feces_composition | 1.55262088 |
40 | MP0005666_abnormal_adipose_tissue | 1.52669610 |
41 | MP0003890_abnormal_embryonic-extraembry | 1.49081649 |
42 | MP0005330_cardiomyopathy | 1.46127942 |
43 | MP0003186_abnormal_redox_activity | 1.44792149 |
44 | MP0002254_reproductive_system_inflammat | 1.42175870 |
45 | MP0003221_abnormal_cardiomyocyte_apopto | 1.41992892 |
46 | MP0009643_abnormal_urine_homeostasis | 1.38972935 |
47 | MP0000350_abnormal_cell_proliferation | 1.37823191 |
48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.37708164 |
49 | MP0010307_abnormal_tumor_latency | 1.37182201 |
50 | MP0001697_abnormal_embryo_size | 1.36648298 |
51 | MP0010234_abnormal_vibrissa_follicle | 1.33847394 |
52 | MP0002102_abnormal_ear_morphology | 1.33064977 |
53 | MP0009697_abnormal_copulation | 1.31412735 |
54 | MP0001672_abnormal_embryogenesis/_devel | 1.31192999 |
55 | MP0005380_embryogenesis_phenotype | 1.31192999 |
56 | MP0001764_abnormal_homeostasis | 1.29397693 |
57 | MP0000598_abnormal_liver_morphology | 1.29144475 |
58 | MP0008995_early_reproductive_senescence | 1.27747909 |
59 | MP0002160_abnormal_reproductive_system | 1.26518427 |
60 | MP0001529_abnormal_vocalization | 1.22551458 |
61 | MP0004185_abnormal_adipocyte_glucose | 1.21850733 |
62 | MP0003984_embryonic_growth_retardation | 1.15605945 |
63 | MP0002088_abnormal_embryonic_growth/wei | 1.15435914 |
64 | MP0002971_abnormal_brown_adipose | 1.13441927 |
65 | MP0002080_prenatal_lethality | 1.10520103 |
66 | MP0002822_catalepsy | 1.09221708 |
67 | MP0005220_abnormal_exocrine_pancreas | 1.08101776 |
68 | MP0000358_abnormal_cell_content/ | 1.07940557 |
69 | MP0003123_paternal_imprinting | 1.06458835 |
70 | MP0005501_abnormal_skin_physiology | 1.05454767 |
71 | MP0009763_increased_sensitivity_to | 1.05149393 |
72 | MP0005334_abnormal_fat_pad | 1.04679230 |
73 | MP0006036_abnormal_mitochondrial_physio | 1.03124537 |
74 | MP0004084_abnormal_cardiac_muscle | 1.03040478 |
75 | MP0002876_abnormal_thyroid_physiology | 1.02181963 |
76 | MP0006054_spinal_hemorrhage | 1.01755246 |
77 | MP0003656_abnormal_erythrocyte_physiolo | 1.00236960 |
78 | MP0008877_abnormal_DNA_methylation | 0.99559853 |
79 | MP0003119_abnormal_digestive_system | 0.98215770 |
80 | MP0000313_abnormal_cell_death | 0.97269569 |
81 | MP0002078_abnormal_glucose_homeostasis | 0.95173671 |
82 | MP0008469_abnormal_protein_level | 0.95009190 |
83 | MP0010368_abnormal_lymphatic_system | 0.94946087 |
84 | MP0006138_congestive_heart_failure | 0.94934630 |
85 | MP0002090_abnormal_vision | 0.93915751 |
86 | MP0006072_abnormal_retinal_apoptosis | 0.92610298 |
87 | MP0005375_adipose_tissue_phenotype | 0.92446341 |
88 | MP0002166_altered_tumor_susceptibility | 0.92247608 |
89 | MP0009764_decreased_sensitivity_to | 0.90337087 |
90 | MP0001293_anophthalmia | 0.89982748 |
91 | MP0003137_abnormal_impulse_conducting | 0.89471221 |
92 | MP0003300_gastrointestinal_ulcer | 0.89120417 |
93 | MP0005385_cardiovascular_system_phenoty | 0.87879951 |
94 | MP0001544_abnormal_cardiovascular_syste | 0.87879951 |
95 | MP0005367_renal/urinary_system_phenotyp | 0.87229914 |
96 | MP0000516_abnormal_urinary_system | 0.87229914 |
97 | MP0001929_abnormal_gametogenesis | 0.86950526 |
98 | MP0005636_abnormal_mineral_homeostasis | 0.85789337 |
99 | MP0009053_abnormal_anal_canal | 0.85271930 |
100 | MP0002009_preneoplasia | 0.84956919 |
101 | MP0008438_abnormal_cutaneous_collagen | 0.84543653 |
102 | MP0002084_abnormal_developmental_patter | 0.84174143 |
103 | MP0009642_abnormal_blood_homeostasis | 0.83585035 |
104 | MP0003724_increased_susceptibility_to | 0.83213047 |
105 | MP0002210_abnormal_sex_determination | 0.82541689 |
106 | MP0002085_abnormal_embryonic_tissue | 0.82452660 |
107 | MP0000653_abnormal_sex_gland | 0.82235798 |
108 | MP0004147_increased_porphyrin_level | 0.82114530 |
109 | MP0002970_abnormal_white_adipose | 0.81950717 |
110 | MP0001145_abnormal_male_reproductive | 0.81742091 |
111 | MP0009115_abnormal_fat_cell | 0.81470758 |
112 | MP0002060_abnormal_skin_morphology | 0.80392917 |
113 | MP0002972_abnormal_cardiac_muscle | 0.79151649 |
114 | MP0003011_delayed_dark_adaptation | 0.76834686 |
115 | MP0005647_abnormal_sex_gland | 0.76639494 |
116 | MP0002019_abnormal_tumor_incidence | 0.74905305 |
117 | MP0000372_irregular_coat_pigmentation | 0.74519379 |
118 | MP0002796_impaired_skin_barrier | 0.74479248 |
119 | MP0004264_abnormal_extraembryonic_tissu | 0.74105363 |
120 | MP0008789_abnormal_olfactory_epithelium | 0.73796841 |
121 | MP0002127_abnormal_cardiovascular_syste | 0.73265420 |
122 | MP0001756_abnormal_urination | 0.73250609 |
123 | MP0001881_abnormal_mammary_gland | 0.73061055 |
124 | MP0001188_hyperpigmentation | 0.71826831 |
125 | MP0008872_abnormal_physiological_respon | 0.71492831 |
126 | MP0002086_abnormal_extraembryonic_tissu | 0.71451627 |
127 | MP0005464_abnormal_platelet_physiology | 0.71220006 |
128 | MP0009672_abnormal_birth_weight | 0.70877411 |
129 | MP0005275_abnormal_skin_tensile | 0.70735062 |
130 | MP0003315_abnormal_perineum_morphology | 0.69888605 |
131 | MP0005408_hypopigmentation | 0.69794067 |
132 | MP0001661_extended_life_span | 0.69275422 |
133 | MP0001853_heart_inflammation | 0.69112961 |
134 | MP0010352_gastrointestinal_tract_polyps | 0.68161545 |
135 | MP0010630_abnormal_cardiac_muscle | 0.67469846 |
136 | MP0005451_abnormal_body_composition | 0.66374248 |
137 | MP0003436_decreased_susceptibility_to | 0.66258217 |
138 | MP0009765_abnormal_xenobiotic_induced | 0.65992268 |
139 | MP0002837_dystrophic_cardiac_calcinosis | 0.65967567 |
140 | MP0005448_abnormal_energy_balance | 0.65194616 |
141 | MP0005535_abnormal_body_temperature | 0.64112495 |
142 | MP0004782_abnormal_surfactant_physiolog | 0.62977584 |
143 | MP0005376_homeostasis/metabolism_phenot | 0.58150073 |
144 | MP0005248_abnormal_Harderian_gland | 0.57938274 |
145 | MP0002136_abnormal_kidney_physiology | 0.57150887 |
146 | MP0003567_abnormal_fetal_cardiomyocyte | 0.55650057 |
147 | MP0000685_abnormal_immune_system | 0.54411512 |
148 | MP0004947_skin_inflammation | 0.54041136 |
149 | MP0003566_abnormal_cell_adhesion | 0.53208349 |
150 | MP0001835_abnormal_antigen_presentation | 0.53000646 |
151 | MP0001944_abnormal_pancreas_morphology | 0.52953732 |
152 | MP0005266_abnormal_metabolism | 0.52922025 |
153 | MP0001845_abnormal_inflammatory_respons | 0.51004172 |
154 | MP0009785_altered_susceptibility_to | 0.50579276 |
155 | MP0005058_abnormal_lysosome_morphology | 0.50258941 |
156 | MP0002396_abnormal_hematopoietic_system | 0.50245991 |
157 | MP0003959_abnormal_lean_body | 0.49520351 |
158 | MP0009379_abnormal_foot_pigmentation | 0.49308592 |
159 | MP0000427_abnormal_hair_cycle | 0.49192332 |
160 | MP0005187_abnormal_penis_morphology | 0.47726365 |
161 | MP0002006_tumorigenesis | 0.47272339 |
162 | MP0001243_abnormal_dermal_layer | 0.46860381 |
163 | MP0001216_abnormal_epidermal_layer | 0.45447789 |
164 | MP0001545_abnormal_hematopoietic_system | 0.45357571 |
165 | MP0005397_hematopoietic_system_phenotyp | 0.45357571 |
166 | MP0003953_abnormal_hormone_level | 0.44361619 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 5.87605947 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.79477955 |
3 | Deep venous thrombosis (HP:0002625) | 5.70930574 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.35245791 |
5 | Xanthomatosis (HP:0000991) | 5.26752260 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.01120982 |
7 | Hypoglycemic coma (HP:0001325) | 4.89201559 |
8 | Prolonged partial thromboplastin time (HP:0003645) | 4.77212007 |
9 | Complement deficiency (HP:0004431) | 4.66257328 |
10 | Hyperlipoproteinemia (HP:0010980) | 4.66138334 |
11 | Hyperammonemia (HP:0001987) | 4.39625229 |
12 | Ketosis (HP:0001946) | 4.22851571 |
13 | Increased serum pyruvate (HP:0003542) | 4.16803524 |
14 | Abnormality of glycolysis (HP:0004366) | 4.04731449 |
15 | Hyperglycinuria (HP:0003108) | 4.04289312 |
16 | Epidermoid cyst (HP:0200040) | 4.00858134 |
17 | Hypolipoproteinemia (HP:0010981) | 3.98031908 |
18 | Hyperglycinemia (HP:0002154) | 3.93514088 |
19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.91271322 |
20 | Abnormality of glycine metabolism (HP:0010895) | 3.85491628 |
21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.85491628 |
22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.84238175 |
23 | Ketoacidosis (HP:0001993) | 3.68795792 |
24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.67102361 |
25 | Hypoalphalipoproteinemia (HP:0003233) | 3.61864173 |
26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.58899780 |
27 | Joint hemorrhage (HP:0005261) | 3.54761884 |
28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.51433708 |
29 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.47121324 |
30 | Abnormality of complement system (HP:0005339) | 3.41780220 |
31 | Hypercholesterolemia (HP:0003124) | 3.40013871 |
32 | Fat malabsorption (HP:0002630) | 3.37683967 |
33 | Acute encephalopathy (HP:0006846) | 3.34698493 |
34 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.31722327 |
35 | Increased hepatocellular lipid droplets (HP:0006565) | 3.15736917 |
36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.12062238 |
37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.05930229 |
38 | Type I transferrin isoform profile (HP:0003642) | 3.02543432 |
39 | Lipid accumulation in hepatocytes (HP:0006561) | 3.02316026 |
40 | Hyperalaninemia (HP:0003348) | 3.02312800 |
41 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.02312800 |
42 | Abnormality of alanine metabolism (HP:0010916) | 3.02312800 |
43 | Acute necrotizing encephalopathy (HP:0006965) | 3.01840891 |
44 | Conjugated hyperbilirubinemia (HP:0002908) | 3.00456980 |
45 | Hypoglycemic seizures (HP:0002173) | 2.92588144 |
46 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.92224554 |
47 | Abnormality of methionine metabolism (HP:0010901) | 2.91888201 |
48 | Reduced antithrombin III activity (HP:0001976) | 2.90787326 |
49 | Hyperbilirubinemia (HP:0002904) | 2.89538864 |
50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.85842807 |
51 | Dicarboxylic aciduria (HP:0003215) | 2.85315682 |
52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.85315682 |
53 | Generalized aminoaciduria (HP:0002909) | 2.84115571 |
54 | Increased CSF lactate (HP:0002490) | 2.83967245 |
55 | Skin nodule (HP:0200036) | 2.82401942 |
56 | Megaloblastic anemia (HP:0001889) | 2.81530033 |
57 | Increased intramyocellular lipid droplets (HP:0012240) | 2.77322240 |
58 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.77015547 |
59 | Hepatic necrosis (HP:0002605) | 2.76854315 |
60 | Myocardial infarction (HP:0001658) | 2.76091488 |
61 | Hepatocellular carcinoma (HP:0001402) | 2.75891207 |
62 | Abnormality of purine metabolism (HP:0004352) | 2.75799096 |
63 | Mitochondrial inheritance (HP:0001427) | 2.70053221 |
64 | Abnormality of serum amino acid levels (HP:0003112) | 2.68637855 |
65 | Increased serum lactate (HP:0002151) | 2.63923060 |
66 | Lactic acidosis (HP:0003128) | 2.63845482 |
67 | Multiple enchondromatosis (HP:0005701) | 2.61554772 |
68 | Chromsome breakage (HP:0040012) | 2.61081691 |
69 | Metabolic acidosis (HP:0001942) | 2.60567294 |
70 | Systemic lupus erythematosus (HP:0002725) | 2.60334678 |
71 | Spastic diplegia (HP:0001264) | 2.60100402 |
72 | Microvesicular hepatic steatosis (HP:0001414) | 2.58988486 |
73 | Renal Fanconi syndrome (HP:0001994) | 2.57532483 |
74 | Delayed CNS myelination (HP:0002188) | 2.56775481 |
75 | Abnormal protein glycosylation (HP:0012346) | 2.55276298 |
76 | Abnormal glycosylation (HP:0012345) | 2.55276298 |
77 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.55276298 |
78 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.55276298 |
79 | Late onset (HP:0003584) | 2.52319476 |
80 | Increased muscle lipid content (HP:0009058) | 2.52247244 |
81 | Palpitations (HP:0001962) | 2.50993373 |
82 | Abnormality of the anterior horn cell (HP:0006802) | 2.49920072 |
83 | Degeneration of anterior horn cells (HP:0002398) | 2.49920072 |
84 | Nausea (HP:0002018) | 2.49505816 |
85 | Neoplasm of the adrenal gland (HP:0100631) | 2.44281866 |
86 | Progressive macrocephaly (HP:0004481) | 2.39255645 |
87 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.38442364 |
88 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.38442364 |
89 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.37849425 |
90 | Birth length less than 3rd percentile (HP:0003561) | 2.37452357 |
91 | Steatorrhea (HP:0002570) | 2.35751912 |
92 | Abnormality of the preputium (HP:0100587) | 2.35108127 |
93 | Hyperglycemia (HP:0003074) | 2.34431876 |
94 | Hepatocellular necrosis (HP:0001404) | 2.33279975 |
95 | Abnormality of the labia minora (HP:0012880) | 2.33183011 |
96 | Meckel diverticulum (HP:0002245) | 2.31268439 |
97 | Methylmalonic acidemia (HP:0002912) | 2.29978906 |
98 | Abnormality of chromosome stability (HP:0003220) | 2.29603556 |
99 | Abnormal gallbladder physiology (HP:0012438) | 2.27816760 |
100 | Cholecystitis (HP:0001082) | 2.27816760 |
101 | Pancreatitis (HP:0001733) | 2.27365826 |
102 | Esophageal varix (HP:0002040) | 2.26590455 |
103 | Abnormal cartilage morphology (HP:0002763) | 2.26385090 |
104 | Hypertriglyceridemia (HP:0002155) | 2.21532628 |
105 | Breast carcinoma (HP:0003002) | 2.19529219 |
106 | Hypochromic microcytic anemia (HP:0004840) | 2.17383993 |
107 | Lethargy (HP:0001254) | 2.17119823 |
108 | Proximal tubulopathy (HP:0000114) | 2.15319940 |
109 | Hydroxyprolinuria (HP:0003080) | 2.14526393 |
110 | Abnormality of proline metabolism (HP:0010907) | 2.14526393 |
111 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.08942936 |
112 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.08942936 |
113 | Single umbilical artery (HP:0001195) | 2.08942936 |
114 | Abnormality of the ileum (HP:0001549) | 2.08715887 |
115 | Acanthocytosis (HP:0001927) | 2.08019512 |
116 | Gingival bleeding (HP:0000225) | 2.05061745 |
117 | Neonatal onset (HP:0003623) | 2.04479057 |
118 | Myoglobinuria (HP:0002913) | 2.03375741 |
119 | Exercise intolerance (HP:0003546) | 2.03253339 |
120 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.02122817 |
121 | Symptomatic seizures (HP:0011145) | 2.01751413 |
122 | Posterior subcapsular cataract (HP:0007787) | 2.00875083 |
123 | Thrombophlebitis (HP:0004418) | 2.00363607 |
124 | Glomerulonephritis (HP:0000099) | 1.99683795 |
125 | Ovarian neoplasm (HP:0100615) | 1.99080052 |
126 | Spontaneous abortion (HP:0005268) | 1.97941503 |
127 | Insulin resistance (HP:0000855) | 1.97054194 |
128 | Cerebral edema (HP:0002181) | 1.95772902 |
129 | Methylmalonic aciduria (HP:0012120) | 1.93847700 |
130 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.93600202 |
131 | Hyperphosphaturia (HP:0003109) | 1.92277387 |
132 | Malnutrition (HP:0004395) | 1.92203502 |
133 | Hemorrhage of the eye (HP:0011885) | 1.90986700 |
134 | Respiratory failure (HP:0002878) | 1.90747824 |
135 | Gout (HP:0001997) | 1.89819987 |
136 | Vomiting (HP:0002013) | 1.89262306 |
137 | Abnormal lung lobation (HP:0002101) | 1.89193513 |
138 | Pancytopenia (HP:0001876) | 1.88137570 |
139 | Menorrhagia (HP:0000132) | 1.87986009 |
140 | Abnormality of the umbilical cord (HP:0010881) | 1.86803897 |
141 | Limb hypertonia (HP:0002509) | 1.85650118 |
142 | Irritability (HP:0000737) | 1.84770997 |
143 | Ragged-red muscle fibers (HP:0003200) | 1.84177254 |
144 | Thyroid carcinoma (HP:0002890) | 1.83983590 |
145 | Testicular atrophy (HP:0000029) | 1.83400484 |
146 | Elevated hepatic transaminases (HP:0002910) | 1.81909118 |
147 | Oligomenorrhea (HP:0000876) | 1.81474697 |
148 | Mitral stenosis (HP:0001718) | 1.80667126 |
149 | Abnormality of urine glucose concentration (HP:0011016) | 1.79923090 |
150 | Glycosuria (HP:0003076) | 1.79923090 |
151 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.79438356 |
152 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.79438356 |
153 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.78635351 |
154 | Sensorimotor neuropathy (HP:0007141) | 1.78502428 |
155 | Brushfield spots (HP:0001088) | 1.78168073 |
156 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.77817354 |
157 | Abnormality of iron homeostasis (HP:0011031) | 1.77748398 |
158 | Hypoplastic left heart (HP:0004383) | 1.77511046 |
159 | Duodenal stenosis (HP:0100867) | 1.77324427 |
160 | Small intestinal stenosis (HP:0012848) | 1.77324427 |
161 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76115850 |
162 | Renal cortical cysts (HP:0000803) | 1.73455860 |
163 | Enlarged kidneys (HP:0000105) | 1.73304137 |
164 | Increased mean platelet volume (HP:0011877) | 1.72552528 |
165 | Rhabdomyolysis (HP:0003201) | 1.72405373 |
166 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.69915450 |
167 | Neonatal hypoglycemia (HP:0001998) | 1.69855073 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 4.55119808 |
2 | BUB1 | 4.16515730 |
3 | TRIB3 | 3.73279720 |
4 | SIK1 | 3.63184701 |
5 | EIF2AK1 | 3.62335726 |
6 | PKN2 | 3.38243868 |
7 | ERN1 | 3.30302794 |
8 | SRPK1 | 3.21135726 |
9 | FLT3 | 3.02691181 |
10 | FGFR4 | 2.92314117 |
11 | TTK | 2.81291152 |
12 | MST4 | 2.78078093 |
13 | VRK2 | 2.69360312 |
14 | TRIM28 | 2.66079694 |
15 | PBK | 2.65655911 |
16 | TSSK6 | 2.57175111 |
17 | PLK4 | 2.38936004 |
18 | INSRR | 2.30054112 |
19 | PDK2 | 2.18412538 |
20 | MAP3K12 | 2.02251887 |
21 | MAP3K10 | 2.01683959 |
22 | WEE1 | 1.96225362 |
23 | TYK2 | 1.95872678 |
24 | TAOK3 | 1.90178418 |
25 | PTK6 | 1.87372186 |
26 | LATS1 | 1.81567062 |
27 | STK16 | 1.78994648 |
28 | MST1R | 1.76419628 |
29 | PLK3 | 1.75813266 |
30 | CAMK1D | 1.73818611 |
31 | EEF2K | 1.72234382 |
32 | NEK9 | 1.71646043 |
33 | PIK3CG | 1.70755173 |
34 | SCYL2 | 1.65465293 |
35 | TGFBR2 | 1.56341309 |
36 | NUAK1 | 1.54304858 |
37 | ZAK | 1.53761999 |
38 | NME1 | 1.52784929 |
39 | IRAK3 | 1.49488080 |
40 | TGFBR1 | 1.48344598 |
41 | VRK1 | 1.46178841 |
42 | MAP2K3 | 1.44213691 |
43 | CDK6 | 1.43329839 |
44 | JAK3 | 1.42549439 |
45 | MAP3K3 | 1.41211829 |
46 | RIPK1 | 1.39432487 |
47 | FGFR3 | 1.38941537 |
48 | PLK1 | 1.38889947 |
49 | FRK | 1.35312662 |
50 | ERBB3 | 1.27171971 |
51 | BCR | 1.24584452 |
52 | MKNK1 | 1.23287659 |
53 | MAPK11 | 1.22850501 |
54 | PASK | 1.21994495 |
55 | EIF2AK2 | 1.21365956 |
56 | BRSK1 | 1.15368364 |
57 | JAK2 | 1.14923085 |
58 | TBK1 | 1.09982795 |
59 | CDK4 | 1.09895646 |
60 | CSNK1G3 | 1.07167427 |
61 | LRRK2 | 1.06183214 |
62 | PDGFRA | 1.06103406 |
63 | WNK3 | 1.04809393 |
64 | JAK1 | 1.03847617 |
65 | MKNK2 | 0.99812617 |
66 | TESK2 | 0.99105929 |
67 | ACVR1B | 0.97877227 |
68 | TAF1 | 0.97590397 |
69 | STK3 | 0.96843024 |
70 | MAP2K7 | 0.96646390 |
71 | ATR | 0.95136957 |
72 | NME2 | 0.93639787 |
73 | CSNK1G1 | 0.93247360 |
74 | KDR | 0.93022317 |
75 | CDK7 | 0.92764737 |
76 | BRSK2 | 0.92563155 |
77 | TESK1 | 0.91536411 |
78 | RPS6KA4 | 0.89221678 |
79 | MAP3K14 | 0.89107680 |
80 | CSNK1G2 | 0.88154925 |
81 | AURKB | 0.85840878 |
82 | CHEK2 | 0.85008215 |
83 | RPS6KB2 | 0.83942217 |
84 | EPHA3 | 0.83095769 |
85 | TIE1 | 0.81819959 |
86 | PRKAA2 | 0.81379161 |
87 | STK24 | 0.77879402 |
88 | PIM2 | 0.77873966 |
89 | MAPKAPK3 | 0.74529953 |
90 | KIT | 0.74284323 |
91 | BMPR1B | 0.73029729 |
92 | NEK1 | 0.72654886 |
93 | PIK3CA | 0.72435894 |
94 | STK39 | 0.69709960 |
95 | ERBB4 | 0.68492031 |
96 | MAP3K2 | 0.67919331 |
97 | ABL2 | 0.67803309 |
98 | CAMK1G | 0.67240433 |
99 | CDC7 | 0.66989252 |
100 | CSNK1A1L | 0.66856282 |
101 | MAP4K1 | 0.66609302 |
102 | MYLK | 0.65998844 |
103 | CSF1R | 0.65651120 |
104 | FGFR2 | 0.63522628 |
105 | DYRK1B | 0.63354376 |
106 | AURKA | 0.61871806 |
107 | TTN | 0.61260273 |
108 | DAPK1 | 0.61004188 |
109 | LMTK2 | 0.60499848 |
110 | CSNK2A1 | 0.60467220 |
111 | OBSCN | 0.60183475 |
112 | MAPKAPK5 | 0.59996645 |
113 | MAPK4 | 0.59906642 |
114 | MAP3K4 | 0.58571772 |
115 | BTK | 0.58360657 |
116 | ZAP70 | 0.57856188 |
117 | ATM | 0.56874484 |
118 | CHEK1 | 0.55420983 |
119 | RET | 0.55336873 |
120 | EIF2AK3 | 0.52977485 |
121 | TEC | 0.52931996 |
122 | MTOR | 0.52374963 |
123 | TNIK | 0.51981653 |
124 | DYRK3 | 0.51688985 |
125 | CSNK2A2 | 0.51268928 |
126 | IRAK1 | 0.51101031 |
127 | MAP3K7 | 0.50003992 |
128 | FGFR1 | 0.49273039 |
129 | TLK1 | 0.48794345 |
130 | CHUK | 0.48781809 |
131 | MET | 0.48762244 |
132 | STK38L | 0.48710193 |
133 | IGF1R | 0.48310791 |
134 | NEK6 | 0.48037998 |
135 | RPS6KA5 | 0.47631134 |
136 | MAP2K4 | 0.47593217 |
137 | PRKAA1 | 0.47150076 |
138 | PDK3 | 0.46388474 |
139 | PDK4 | 0.46388474 |
140 | ERBB2 | 0.46226470 |
141 | MAP3K11 | 0.46057598 |
142 | BRD4 | 0.45802158 |
143 | ALK | 0.45791153 |
144 | PTK2 | 0.45656440 |
145 | IKBKE | 0.45515180 |
146 | GSK3A | 0.45169432 |
147 | OXSR1 | 0.44175008 |
148 | MAP3K8 | 0.43816946 |
149 | STK4 | 0.43171017 |
150 | MAP3K5 | 0.41767184 |
151 | DMPK | 0.41429312 |
152 | CSK | 0.40226743 |
153 | ILK | 0.39405532 |
154 | CCNB1 | 0.39007336 |
155 | PRKACG | 0.38515792 |
156 | MUSK | 0.38231479 |
157 | GRK7 | 0.37606992 |
158 | PAK4 | 0.37307028 |
159 | BRAF | 0.36977373 |
160 | CSNK1E | 0.36156875 |
161 | GRK6 | 0.34114620 |
162 | CDK9 | 0.33639925 |
163 | IRAK4 | 0.33238646 |
164 | STK10 | 0.33163394 |
165 | PRKG2 | 0.32292523 |
166 | MAPK15 | 0.32060483 |
167 | AKT2 | 0.30808542 |
168 | PLK2 | 0.30143996 |
169 | CAMK2D | 0.30092805 |
170 | BMPR2 | 0.27597273 |
171 | SIK3 | 0.27232815 |
172 | PRKCI | 0.26548187 |
173 | CDK1 | 0.26033490 |
174 | CDK2 | 0.25993592 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.89916598 |
2 | Proteasome_Homo sapiens_hsa03050 | 3.74959127 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.17212289 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.10783056 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.94546386 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.77177675 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70928071 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66549279 |
9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.66500618 |
10 | Mismatch repair_Homo sapiens_hsa03430 | 2.55881278 |
11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.52183529 |
12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.51537799 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.35785967 |
14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.32129169 |
15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.24341056 |
16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16384416 |
17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.12683497 |
18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.08927294 |
19 | Peroxisome_Homo sapiens_hsa04146 | 2.04190654 |
20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.01441147 |
21 | Base excision repair_Homo sapiens_hsa03410 | 1.97508930 |
22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.95679426 |
23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.95487928 |
24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87858829 |
25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.86042659 |
26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.83922540 |
27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.83153612 |
28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.78836589 |
29 | Protein export_Homo sapiens_hsa03060 | 1.78162904 |
30 | Homologous recombination_Homo sapiens_hsa03440 | 1.75873016 |
31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.73714892 |
32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72048575 |
33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.71991196 |
34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.69996281 |
35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66812794 |
36 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.65025480 |
37 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.63503086 |
38 | RNA polymerase_Homo sapiens_hsa03020 | 1.57816557 |
39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55952180 |
40 | Spliceosome_Homo sapiens_hsa03040 | 1.55776462 |
41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.55587060 |
42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.54252977 |
43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54139554 |
44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53158257 |
45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50948068 |
46 | RNA transport_Homo sapiens_hsa03013 | 1.50655685 |
47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.50537864 |
48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.49766310 |
49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.48319635 |
50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.45046664 |
51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44275338 |
52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42466060 |
53 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.41756691 |
54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.41636910 |
55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.37106055 |
56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.34441688 |
57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31128173 |
58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30484616 |
59 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25187849 |
60 | Cell cycle_Homo sapiens_hsa04110 | 1.21763468 |
61 | ABC transporters_Homo sapiens_hsa02010 | 1.18653315 |
62 | Bile secretion_Homo sapiens_hsa04976 | 1.18229790 |
63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15862435 |
64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14006582 |
65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.13581705 |
66 | RNA degradation_Homo sapiens_hsa03018 | 1.11097905 |
67 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.10070973 |
68 | Lysine degradation_Homo sapiens_hsa00310 | 1.08962847 |
69 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08060787 |
70 | Huntingtons disease_Homo sapiens_hsa05016 | 1.01008531 |
71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98657791 |
72 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97088381 |
73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92068345 |
74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89822202 |
75 | Ribosome_Homo sapiens_hsa03010 | 0.89411837 |
76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88501792 |
77 | Purine metabolism_Homo sapiens_hsa00230 | 0.85208902 |
78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83184173 |
79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76793836 |
80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.75486675 |
81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74979885 |
82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73390924 |
83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72843838 |
84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72597013 |
85 | Insulin resistance_Homo sapiens_hsa04931 | 0.68105698 |
86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68037726 |
87 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67658657 |
88 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.65810030 |
89 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58457089 |
90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55781196 |
91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47759069 |
92 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46128471 |
93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43318888 |
94 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41677797 |
95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39976196 |
96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39014817 |
97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37936151 |
98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.37876320 |
99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36241833 |
100 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.28898124 |
101 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.28632089 |
102 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.27312404 |
103 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.24346557 |
104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23863517 |
105 | Prion diseases_Homo sapiens_hsa05020 | 0.21749463 |
106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21400334 |
107 | Legionellosis_Homo sapiens_hsa05134 | 0.20992525 |
108 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.20347588 |
109 | Thyroid cancer_Homo sapiens_hsa05216 | 0.19456972 |
110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.16810693 |
111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.14737504 |
112 | DNA replication_Homo sapiens_hsa03030 | 0.12144005 |
113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.11436469 |
114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.10615134 |
115 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.08299699 |
116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.07344401 |
117 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.06716110 |
118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.06499047 |
119 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.05603324 |
120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.01955578 |
121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01786938 |
122 | Hepatitis C_Homo sapiens_hsa05160 | 0.00650113 |
123 | Amoebiasis_Homo sapiens_hsa05146 | -0.0467115 |
124 | Pertussis_Homo sapiens_hsa05133 | -0.0397433 |
125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0279752 |
126 | Antigen processing and presentation_Homo sapiens_hsa04612 | -0.0254582 |
127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0203347 |
128 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.0136050 |
129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0106921 |
130 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0073026 |
131 | Herpes simplex infection_Homo sapiens_hsa05168 | -0.0054996 |